Research on Evaluation of Treatment Response to Active Pulmonary Tuberculosis with Ultra Low Dose CT Based on Deep Learning

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400088684

Enrollment

Unknown

Registered

2024-08-23

Start date

2024-08-23

Completion date

Unknown

Last updated

2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary tuberculosis

Interventions

Gold Standard:Clinical control dose CT

Index test:Deep learning reconstruction (DLR)-based ultra-low-dose (ULD) CT

Eligibility

Sex/Gender

All

Age

22 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1: Voluntary signing of informed consent form 2: Patients over 22 years old 3: Tuberculosis patients diagnosed according to the Health Industry Standards of the People's Republic of China - Diagnostic Criteria for Pulmonary Tuberculosis 4: The previous imaging showed characteristics of active pulmonary tuberculosis (tree bud sign, ground glass, consolidation, thick walled cavity, etc.); (5) Receiving standardized anti tuberculosis treatment 5: Simultaneously undergo routine dose CT and ULDCT examinations

Exclusion criteria

Exclusion criteria: 1: Simultaneously suffering from other infectious lesions in the lungs 2: Pregnant or planned pregnant patients within one year 3: CT images do not meet the requirements (severe artifacts)

Design outcomes

Primary

Measure	Time frame
contrast to noise ratio;Lesion clarity;The accuracy of determining lesion changes;Image noise;	—

Secondary

Measure	Time frame
radiation dosage;	—

Countries

China

Contacts

Public ContactMingzhu Liang

the Fifth Affiliated hospital of Sun Yat-sen University

liangmzh5@mail.sysu.edu.cn+86 137 9897 4827

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026